Smart science to improve lives™
Abrir búsqueda Canasta 0 Ver carrito
Pharma

ALC-0159

Methoxypolyethyleneglycoloxy(2000)-N,N-ditetradecylacetamide

ALC-0159 is a polyethylene glycol (PEG)-lipid conjugate also called a PEGylated lipid. ALC-0159 is a lipid excipient that can be used to form lipid nanoparticles (LNPs). 

PEGylated lipids allow increased circulation times of LNP delivery systems due to their ability to circumvent systemic clearance.

ALC-0159 structure lipid nanoparticle, croda pharma, avanti polar lipids

Click here to contact us today to discuss this product and request your sample!

Nucleic acid

DMG-PEG 2000

PEG (Polymer) - Lipid Conjugates
View
Nucleic acid

DSPE PEG2000

PEG (Polymer) - Lipid Conjugates
View

Lipid supporting services

CDMO cGMP manufacturing

CDMO project management from R&D through to commercialization. Contract manufacturing of proprietary lipid products.

Custom synthesis

Synthesis of research use materials for a variety of applications. Custom synthesis of reference standards or impurities.

Formulation

Development of a suitable formulation for lipid-based delivery systems. Custom lipid blends for use in delivery or diagnostic applications.
man in lab with blue wash over image

Why partner with us?

Support from concept to commercial

It starts with having the leading lipid technology experts in synthesis and formulation and approaching the discovery process in a collaborative nature, then having the expertise to transfer those learnings into a GMP manufacturing environment to support clinical development. And finally, having the commercial production capability to support launch and commercial supply.

Our full range of services include process chemistry, scale-up manufacturing, supply chain management with analytical and regulatory requirements. Our experienced staff of chemists and lipid analysts are ready to meet your development needs with pre-clinical through phase III and commercial launch, speak to one of our experts today!

Get in touch